Day: January 31, 2017

Letter: Lawmakers should treat Utahns as adults

The ground trembled today: Are we having an earthquake? Was this the march to Utah’s Capitol? Or the trembling of fear once Donald J. Trump became president? No, it was none of these things. It was Utah smokers tramping to Idaho and Wyoming to bring back contraband cigarettes.

Jefferson researchers reveal new insight into two states of viral protein

To generate swarms of new viral particles, a virus hijacks a cell into producing masses of self-assembling cages that are then loaded with the genetic blueprint for the next infection. But the picture of how that DNA is loaded into those viral cages, or capsids, was blurry, especially for two of the most common types of DNA virus on earth, bacterial viruses and human herpesvirus.

First stem cell study could lead to development of therapy to reduce inflammation caused by CF

A 39-year-old man with cystic fibrosis made history by becoming the first person to receive human adult stem cells in a new research study that researchers hope will someday lead to the development of a therapy to reduce the inflammation and infection caused by CF. The pioneering subject in the study is Bob Held from Alliance, Ohio, who on Jan. 26 received an infusion of cells called allogeneic human mesenchymal stem cells , adult stem cells collected from the bone marrow of healthy volunteers.

Guest column: Open letter on DeVos

Betsy DoVos, Trump’s nominee for Secretary of Education could drain much-needed funds from public education, writes Kim Jockush. As we transition to a new administration whose leadership can make our country greater, or whose leadership can dismantle the institutions that made our country great in the first place, I implore you to consider carefully the credentials of those appointed by Mr. Trump.

PREVIEW: Donna Dunn (left) at the show in London

THE mother of an inspirational teenager from Cwmbran honoured the wish of her daughter by attending a preview performance of a new musical. Aged only 18, Emily Clark passed away in March of last year from breathing difficulties having previously beaten blood cancer on two occasions.

Getting the mummy guilts over the great dummy divide

COLD COFFEE: I think every parent has had a moment – or 10, or 50 – where they thought that something they were doing was enabling their child, or ‘creating a rod for their own back’ or that your actions or inactions were causing you to raise a terrible human. I’ve had the mummy guilts over everything.

Blue Angels sting Lady Hornets

That’s because, chances are, the Gallia Academy senior will remember her final minute on Monday night for a long time to come. After briefly leaving the game due to an injured left knee, Jenkins checked back in to score five final-minute points – and more importantly lead the host Blue Angels to a 50-42 Ohio Valley Conference girls basketball victory over the Coal Grove Lady Hornets.

Autonomic response during bladder hydrodistention reflects the…

Aims To evaluate the correlation between symptom severity of bladder pain syndrome/interstitial cystitis and autonomic nervous system activity, we examined autonomic responses during bladder hydrodistention. Methods Medical records were collected from a prospective database for patients who underwent bladder hydrodistention with a fixed protocol from March 2012 to December 2013.

Neuron-astrocyte signaling is preserved in the aging brain

Astrocytes play crucial roles in brain homeostasis and are emerging as regulatory elements of neuronal and synaptic physiology by responding to neurotransmitters with Ca2+ elevations and releasing gliotransmitters that activate neuronal receptors. Aging involves neuronal and astrocytic alterations, being considered risk factor for neurodegenerative diseases.

vacuum sucks away breast cancer tumour

A British hospital has made history by becoming the first in the world to remove a cancerous breast tumour under local anaesthetic using a vacuum. It is the first time ever the innovative non-surgical procedure has been used to treat a malignant breast cancer tumour.

Novartis pushing its CAR-T cancer treatment

Novartis is pushing ahead with one of its most ambitious cancer therapies, a treatment that the Swiss drugmaker says has blockbuster potential as it extends that technology to a wider pool of tumor-ridden patients. Europe’s second-biggest drugmaker is planning to test its CAR-T treatments — which involve extracting immune cells and genetically engineering them to hunt and kill cancer cells before returning them into the patient’s body — on lethal cancers of the brain, pancreas, colon, ovary and lung.